elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46207877-34DCB0E1-1EA1-40E6-86A7-50BF008EA66F
Q46207877-34DCB0E1-1EA1-40E6-86A7-50BF008EA66F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46207877-34DCB0E1-1EA1-40E6-86A7-50BF008EA66F
Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.
P2860
Q46207877-34DCB0E1-1EA1-40E6-86A7-50BF008EA66F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46207877-34DCB0E1-1EA1-40E6-86A7-50BF008EA66F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56c5fb9b70a647fe389c24a13e442cdadc2a7e5c
P2860
Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib.